Crinetics Pharmaceuticals (CRNX) Announces Proposed Common Share Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. BMY
2. LBRX
3. MRK
4. TRAX
5. LMT
6. KTOS
7. FATE
8. FFAI
9. MSFT
10. IRIX

Go back to Crinetics Pharmaceuticals (CRNX) Announces Proposed Common Share Offering

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

April 14, 2020 4:04 PM EDT

SAN DIEGO, April 14, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. In addition, Crinetics intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. All of the shares to... More